Global Trust Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$4.71K 468
2024
Q4
$4.71K Buy
+200
New +$4.92K ﹤0.01% 443
2024
Q3
Sell
-200
Closed -$4.7K 491
2024
Q2
$4.7K Hold
200
﹤0.01% 389
2024
Q1
$5.75K Sell
200
-100
-33% -$3.01K ﹤0.01% 378
2023
Q4
$9.84K Buy
+300
New +$8.16K ﹤0.01% 340
2023
Q3
Sell
-600
Closed -$20.5K 448
2023
Q2
$20.5K Buy
+600
New +$18.9K 0.01% 291
2022
Q2
Sell
-538
Closed -$25K 403
2022
Q1
$25K Hold
538
0.01% 322
2021
Q4
$33K Sell
538
-46
-8% -$3.18K 0.01% 282
2021
Q3
$44K Sell
584
-102
-15% -$8.56K 0.02% 249
2021
Q2
$63K Sell
686
-2,688
-80% -$229K 0.03% 243
2021
Q1
$299K Sell
3,374
-1,238
-27% -$123K 0.16% 123
2020
Q4
$430K Sell
4,612
-1,659
-26% -$132K 0.24% 104
2020
Q3
$406K Sell
6,271
-4,435
-41% -$260K 0.26% 100
2020
Q2
$558K Buy
10,706
+2,600
+32% +$112K 0.39% 71
2020
Q1
$259K Buy
8,106
+7,206
+801% +$241K 0.2% 124
2019
Q4
$30K Buy
+900
New +$28.6K 0.02% 250

Other funds holding ARKG

Global Trust Asset Management's ARKG Position: Q1 2025 in Review

Global Trust Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 200 shares — an estimated $4.71K sold.

Global Trust Asset Management first reported a position in ARKG in Q4 2019 and held it in 15 quarters. The position peaked at $558K in Q2 2020. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

  • Global Trust Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
  • Global Trust Asset Management sold 200 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $4.71K.
  • Global Trust Asset Management first reported a position in ARK Genomic Revolution ETF in Q4 2019 and held it in 15 quarters.
  • Global Trust Asset Management's ARK Genomic Revolution ETF position peaked at $558K in Q2 2020.
  • 214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Global Trust Asset Management's 13F filing for Q1 2025, filed 18 Apr 2025.